4P-Pharma team will participate to the annual La Parisienne race on September 11, 2016. La Parisienne is an annual race occurring in Paris. Each year, some of the benefits of the race are used to raise awareness and support medical research against breast cancer.
Signature of a license agreement between 4P-Pharma, SATT-Aquitaine and University of Bordeaux for the development of an anti-cancer drug. Talence, September 1st 4P-Pharma has signed an exclusive license agreement with Aquitaine Science Transfert, for the development of a drug targeting pancreatic cancer, triple negative breast cancer or colon cancer. The molecule was first developed&hellip